MannKind Corporation to Present at The 26th Annual Piper Jaffray Healthcare Conference

VALENCIA, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation MNKD, focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that it will present at The 26^th Annual Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014 at 3:00 PM (ET) at the New York Palace Hotel in New York City.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.

About MannKind Corporation

MannKind Corporation MNKD focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.